Eisai Inc. has announced the appointments of Yuji Matsue as chairman and chief executive officer and Shaji Procida as president and chief operating officer, effective April 1, 2014. Mr. Matsue and Ms. Procida succeed current President and CEO Lonnel Coats, who will be retiring from Eisai in June 2014 after 18 years.
DPx Launches as Global Provider of Pharmaceutical Services, Fine Chemicals and Proprietary TechnologiesMarch 11, 2014 3:16 pm | Comments
Formerly known by its provisional name “NewCo,” DPx is the corporate parent of a group of...
An innovative hepatitis C drug that was only recently hailed as a breakthrough treatment is...
With the merger, the company extends its global footprint to include 20 operational offices in...
A first-time mother who says she failed a drug test while in labor because she ate poppy seeds is suing a Pittsburgh hospital and says officials defamed her and violated her doctor-patient confidentiality by sharing the results with a child welfare agency.
This session will provide an update on the PDA Task Force that is discussing strategies and risk management of Aging Facilities, and discuss some specific examples of unique challenges that manufacturers must deal with these facilities to maintain Good Manufacturing Practices.
President Barack Obama is hamming it up online to promote his health care plan. Obama joked Tuesday with comedian Zach , including poking fun at the poorly reviewed "Hangover Part III" during an interview on the website Funny or Die.
Romark Laboratories will complete the advanced development of Nitazoxanide (NT-300) as a treatment for acute uncomplicated influenza in a Phase III clinical study using the integrated eClinical products and services from DSG.
The Obama administration says it's pulling the plug on proposed changes to the Medicare prescription program that ran into strong opposition on Capitol Hill.
U.S. Sen. Joe Manchin is calling on the government's top health official to overturn the approval of a powerful painkiller, arguing that the pill Zohydro could add to the national epidemic of prescription drug abuse.
Uninsured Americans face an important deadline at the end of this month, and many don't realize it.
In a new agreement, PBI will provide access to its extensive menu of validated biomarker assays to support WuXi's integrated clinical trial testing services. This includes bioanalysis and central laboratory services for pharmaceutical and biotech companies performing clinical drug development in China.
Almac has announced the expansion of its clinical services and technologies capabilities to include on-the-ground leadership as well as technical, project and operational resources in Asia. The company has established regional hubs in Singapore and Japan to better enable the industry’s growing need to conduct clinical trials in Asia and/or manage global trials from the region.
A new center at the University of Kansas Medical Center that focuses on stem cell research is conducting clinical trials only eight months after it opened.
It's not just grandma with a new hip and your uncle with a new knee. More than 2 of every 100 Americans now have an artificial joint, doctors are reporting. Among those over 50, it's even more common: Five percent have replaced a knee and more than 2 percent, a hip.
Alexion Pharmaceuticals raised its 2014 guidance on Monday, saying the national health agency of France will reimburse it for past sales of its drug Soliris.
The Water Interest Group addresses topics in pharmaceutical water quality, analytical and microbiological control, rouging and biofilm concerns, continued water monitoring and compendial issues. The interest group is providing for an on-going forum for the exchange and dissemination of information and ideas for the purpose of education, innovation, and compliance related to purified water science.
Harvard Bioscience, a global developer, manufacturer, and marketer of a broad range of tools to advance life science research, has named Ronald Aplin to Vice President Global Operations and Quality, effective immediately.
The Supreme Court has rejected an appeal from a Pennsylvania school district that wants to prevent students from wearing "I (heart) Boobies!" bracelets to promote breast cancer awareness among young people.